Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Regeneron said it began late-stage clinical trials to assess the effectiveness of its antibody cocktail.
via FOX BUSINESS NEWS Markets
https://ift.tt/2ZEm5cs
Trending FOX BUSINESS News: Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Regeneron said it began late-stage clinical trials to assess the effectiveness of its antibody cocktail.
via FOX BUSINESS NEWS Markets
https://ift.tt/2ZEm5cs
0 comments:
Post a Comment